Grifols SA
NASDAQ:GRFS

  • LAST PRICE
    6.3050
  • TODAY'S CHANGE (%)
    0.0050 (0.0794%)
  • Bid / Lots
    6.1500/ 10
  • Ask / Lots
    6.6200/ 1
  • Open / Previous Close
    6.2000 / 6.3000
  • Day Range
    6.1250
    6.4000
  • 52 Week Range
    5.3001
    12.1499
  • Volume
    1,319,401

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
GRFS
Grifols SA
5.2B
20.9x
---
ICLR
ICON PLC
25.9B
38.0x
+4.68%
CRL
Charles River Laboratories International Inc
10.6B
24.2x
+15.57%
FTRE
Fortrea Holdings Inc
2.1B
-20.7x
---
INCY
Incyte Corp
13.6B
18.4x
+39.11%
EXAS
Exact Sciences Corp
7.8B
-31.9x
---
As of 2024-06-30

Company Information

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.

Contact Information

Headquarters
C/ Jesus y Maria, 6BARCELONA, BAR, Spain 08022
Phone
---
Fax
---

Executives

Chairman, Executive Director
Thomas Glanzmann
Chief Executive Officer, Executive Director
Jose Ignacio Abia
Chief Financial Officer
Alfredo Arroyo Guerra
President - Plasma Procurement
Jordi Balsells Valls
President - Bio Supplies
Alberto Grifols Roura

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$5.2B
Revenue (TTM)
$7.1B
Shares Outstanding
687.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.49
EPS
$0.30
Book Value
$9.19
P/E Ratio
20.9x
Price/Sales (TTM)
0.7
Price/Cash Flow (TTM)
6.8x
Operating Margin
14.31%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.